ai3Bio develops treatments to transform the lives of patients with cancer.
ai3Bio has raised $48.0M in total funding. The most recent round was Series A. The last funding was announced in September 2026.
ai3Bio's investors include Ziff Capital Partners, UPMC Enterprises, Tanis ventures, Cockrell Interests.
ai3Bio is headquartered in Pittsburgh, United States.
ai3Bio develops treatments to transform the lives of patients with cancer.
ai3Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ai3Bio — Funding & Investors." VCBacked, September 29, 2026, https://www.vcbacked.co/company/novasenta. Accessed November 14, 2026.
VCBacked. (2026). ai3Bio — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/novasenta
{{cite web |title=ai3Bio — Funding & Investors |url=https://www.vcbacked.co/company/novasenta |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at ai3Bio? Request a listing update